Nektar Therapeutics (NASDAQ:NKTR) Q1 2025 Earnings Call Transcript May 8, 2025
Nektar Therapeutics misses on earnings expectations. Reported EPS is $-0.22 EPS, expectations were $-0.18.
Operator: Good day and thank you for standing by. Welcome to the Nektar Therapeutics First Quarter 2025 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. Please be advised that today’s...
